Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2026-01-12 @ 12:05 PM
Study NCT ID:
NCT00749333
Status:
COMPLETED
Last Update Posted:
2009-04-30
First Post:
2008-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1320C00001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Harsukh Parmar, Medical Science Director, Respiratory and Inflammation Emerging Product Team
Old Organization:
AstraZeneca Pharmaceuticals